Buhari, Osinbajo to Receive Oxford/Astrazeneca #COVID19Vaccine Publicly On Saturday

The Executive Director of the National Primary Health Care Development Agency (NPHCDA), Faisal Shuaib, disclosed this at the second edition of the State House weekly briefing held at the Presidential Villa Abuja.

Shuaib said that the President and the Vice President will receive the Oxford/AstraZeneca COVID-19 vaccine on Saturday after some frontline health workers are vaccinated on Friday.

He also said that the Chairman of the Presidential Task Force on COVID-19 (PTF) and Secretary to the Government of the Federation, SGF, Boss Mustapha will also receive his first dose of the vaccine on the same day.

Also speaking, the Director-General, of the Nigeria Centre for Disease Control, NCDC, Dr. Chikwe Iheakwazu, said that as much as vaccines provide some very important light, the response of testing, surveillance, protecting health workers, investing in national health security, driving risk communications, etc. has to continue.

Director-General of the National Agency for Food Drugs and Administration Control (NAFDAC), Prof. Mojisola Adeyeye, said since the arrival of the vaccine to the country on Tuesday, the agency has been carrying out series of checks on the efficacy of the vaccine.

She said that the agency and the NPHCDA are working closely to ensure a smooth rollout of the vaccination. She also warned that falsified COVID-19 vaccines are already in the global market.

She said, “That’s why NAFDAC is focusing on track-and-trace, to ensure no infiltration of substandard vaccines in the supply chain. Traceability is very important; we can trace the vaccines from the airport to the patient.”

The Minister of Health, Dr. Osagie Ehanire, warned that as a country, Nigeria has been lucky so far but, “we must not stretch our luck. We must continue with our non-pharmaceutical measures.

“We must look at the vaccine as a game-changer, but make no mistake that it’s a replacement for everything else. It is an additional strategy. Vaccines are an addition to the existing response, not a replacement.”